Our Grants - Helmsley Charitable Trust

GRANT	DATE	AMOUNT	PROGRAM
Stichting Health Action International Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study Phase IV	11.20.2023	$3,499,991.00	Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc. Pregnancy Data Repository to Assess Management of Type 1 Diabetes with Diabetes Technology (PRAM-T1D)	11.20.2023	$3,928,454.00	Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc. Leveraging new ultra-rapid insulins with AID for exercise management with T1D	11.20.2023	$1,217,662.00	Type 1 Diabetes, Improve Outcomes
The City of Hope CD318 mediated regulation of islet autoantigen specific T cell immunity	11.08.2023	$905,300.00	Type 1 Diabetes, Prevent & Delay
The Regents of the University of Colorado, Denver Impact of menstruation on glycemic response and exercise	10.19.2023	$2,462,329.00	Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc. Educational intervention to support Diabetes Guidance for Exercise (EDGE)	10.19.2023	$1,425,628.00	Type 1 Diabetes, Improve Outcomes
Université Catholique de Louvain Search for mechanisms responsible for the impaired glucagon secretion in T1D and for strategies to correct them	10.19.2023	$907,500.00	Type 1 Diabetes, Prevent & Delay
Board of Trustees of the Leland Stanford Junior University Development of Personalized Decision Support tool using NetIOB to help manage exercise for people with T1D	10.19.2023	$2,206,910.00	Type 1 Diabetes, Improve Outcomes
The Regents of the University of California, Santa Barbara Exercise specific AID algorithm for Type 1 Diabetes	10.04.2023	$2,977,229.00	Type 1 Diabetes, Improve Outcomes
The Regents of the University of California, San Francisco Identification and analysis of extreme forms of type 1 diabetes, establishment of a data commons	10.04.2023	$1,299,998.00	Type 1 Diabetes, Prevent & Delay
JDRF International Joining Forces: Building a Shared 'Grand Access Strategy' For Saving T1D Lives	09.19.2023	$1,000,000.00	Type 1 Diabetes, Improve Outcomes
Université de Genève Preclinical testing of S100A9 to improve glycemic control in type 1 diabetes	09.19.2023	$2,485,485.00	Type 1 Diabetes, Prevent & Delay
Regents of the University of Minnesota Engineering antigen-specific regulatory T cells for use in type 1 diabetes (Phase 3)	09.19.2023	$1,508,250.00	Type 1 Diabetes, Prevent & Delay
Regents of the University of Minnesota Therapeutic use of peptide:MHC mAbs for T1D	09.19.2023	$660,000.00	Type 1 Diabetes, Prevent & Delay
International Alliance for Diabetes Action Inc Seed funding support	09.06.2023	$2,579,400.00	Type 1 Diabetes, Improve Outcomes
Benaroya Research Institute at Virginia Mason TruCulture sample analysis for TN22 HCQ	08.09.2023	$297,957.00	Type 1 Diabetes, Prevent & Delay
Vayu Health Vayu Health Phase 2 - Scale and Spread of Value Based Payment Ecosystem for Medicaid Beneficiaries Living with Type 1 and Type 2 Diabetes	08.09.2023	$14,445,966.00	Type 1 Diabetes, Improve Outcomes
University of Florida Generating autoantigen-specific antibody-producing hybridomas as a renewable source of islet autoantibodies	08.09.2023	$118,137.00	Type 1 Diabetes, Prevent & Delay
University of Exeter B cell signatures in Type 1 Diabetes	08.09.2023	$800,596.00	Type 1 Diabetes, Prevent & Delay
The Regents of the University of Colorado, Denver T and B cell Receptor Atlas Across Tissues and Stages of Type 1 Diabetes	07.24.2023	$1,503,000.00	Type 1 Diabetes, Prevent & Delay
You can filter rows: 1 - 20 of 858 < > Last